Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

GKOS

Glaukos Corporation

Sep 20 • 04:00PM ET

127.78

Dollar change -2.29
Percentage change -1.76	%

Healthcare • Medical Devices • USA • NYSE

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: IJR VTI IWM VB VXF VBK IJT SPSM IWO IHI

Index	RUT	P/E	-	EPS (ttm)	-3.20	Insider Own	3.62%	Shs Outstand	54.95M	Perf Week	1.19%
Market Cap	7.02B	Forward P/E	-	EPS next Y	-1.37	Insider Trans	-5.97%	Shs Float	52.96M	Perf Month	-1.71%
Income	-158.61M	PEG	-	EPS next Q	-0.48	Inst Own	98.54%	Short Float	4.84%	Perf Quarter	13.06%
Sales	341.73M	P/S	20.55	EPS this Y	7.95%	Inst Trans	1.23%	Short Ratio	4.41	Perf Half Y	46.00%
Book/sh	12.13	P/B	10.53	EPS next Y	34.66%	ROA	-16.91%	Short Interest	2.57M	Perf Year	68.64%
Cash/sh	4.76	P/C	26.83	EPS next 5Y	8.00%	ROE	-27.49%	52W Range	59.22 - 136.60	Perf YTD	60.75%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-49.95%	ROI	-19.30%	52W High	-6.46%	Beta	1.03
Dividend TTM	-	Quick Ratio	4.67	Sales past 5Y	12.76%	Gross Margin	78.14%	52W Low	115.77%	ATR (14)	4.30
Dividend Ex-Date	-	Current Ratio	5.48	EPS Y/Y TTM	-21.11%	Oper. Margin	-33.14%	RSI (14)	52.30	Volatility	4.09% 3.02%
Employees	907	Debt/Eq	0.24	Sales Y/Y TTM	15.14%	Profit Margin	-46.41%	Recom	1.79	Target Price	135.91
Option/Short	Yes / Yes	LT Debt/Eq	0.24	EPS Q/Q	-46.65%	Payout	-	Rel Volume	2.81	Prev Close	130.07
Sales Surprise	7.68%	EPS Surprise	-0.91%	Sales Q/Q	19.02%	Earnings	Jul 31 AMC	Avg Volume	581.37K	Price	127.78
SMA20	-1.19%	SMA50	2.61%	SMA200	24.09%	Trades		Volume	1,633,501	Change	-1.76%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-10-24	Downgrade	Citigroup	Buy → Neutral	$132
May-06-24	Upgrade	Jefferies	Hold → Buy	$84 → $125
Dec-21-23	Upgrade	JP Morgan	Neutral → Overweight	$66 → $91
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight	$65
Nov-28-23	Initiated	Truist	Buy	$88
Nov-08-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$75 → $83
Jun-07-23	Upgrade	Piper Sandler	Neutral → Overweight	$55 → $80
Dec-22-22	Initiated	Mizuho	Neutral	$48
Dec-19-22	Upgrade	JP Morgan	Underweight → Neutral	$48 → $42
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$57
Oct-14-22	Resumed	Stephens	Overweight	$69
Oct-04-22	Initiated	Needham	Buy	$66
Jul-12-22	Upgrade	Stifel	Hold → Buy	$40 → $60
Feb-03-22	Upgrade	William Blair	Mkt Perform → Outperform
Jan-19-22	Upgrade	Wells Fargo	Underweight → Equal Weight	$56
Jan-18-22	Upgrade	BTIG Research	Neutral → Buy	$61
Nov-03-21	Upgrade	Stephens	Equal-Weight → Overweight	$68
Jul-26-21	Downgrade	Stephens	Overweight → Equal-Weight	$70
Jul-20-21	Downgrade	Wells Fargo	Equal Weight → Underweight	$41
Jul-14-21	Downgrade	William Blair	Outperform → Mkt Perform

Show Previous Ratings

Sep-09-24 05:16AM	Heres Why Glaukos (GKOS) Appreciated in Q2 (Insider Monkey)
Sep-03-24 02:16AM	Better Than Expected Earnings Results Boosted Glaukos Corp (GKOS) in Q2 (Insider Monkey)
Aug-22-24 01:16PM	Glaukos (GKOS) Gains 63.5% YTD: What's Driving the Stock? (Zacks)
Aug-16-24 07:00AM	Glaukos Announces Participation in Upcoming Investor Conferences (Business Wire)
Aug-02-24 07:00PM	Glaukos (GKOS) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
08:50AM	Loading…
08:50AM	Should You Be Bullish on Glaukos Corporation (GKOS)? (Insider Monkey)
Aug-01-24 11:40AM	Q2 2024 Glaukos Corp Earnings Call (Thomson Reuters StreetEvents)
07:31AM	Glaukos (GKOS) Q2 Earnings In Line, Glaucoma Drives Sales (Zacks)
Jul-31-24 09:57PM	GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace)
06:20PM	Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:16PM	Glaukos: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Glaukos Announces Second Quarter 2024 Financial Results (Business Wire)
Jul-24-24 10:01AM	Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jul-22-24 11:27AM	Glaukos (GKOS) Gains 51.9% YTD: What's Driving the Stock? (Zacks)
Jul-10-24 07:00AM	Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31 (Business Wire)
07:38AM	Loading…
Jul-03-24 07:38AM	Here's Why You Should Retain Glaukos (GKOS) Stock for Now (Zacks)
Jun-27-24 12:49PM	Glaukos (GKOS) Reaches 52-Week High: What's Driving the Stock? (Zacks)
03:19AM	Glaukos (GKOS) Stock Jumps 3.7%: Will It Continue to Soar? (Zacks)
Jun-14-24 07:00AM	Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock (Business Wire)
Jun-05-24 12:14PM	Glaukos (GKOS) Gains 40.4% YTD: What's Driving the Rally? (Zacks)
Jun-03-24 01:53PM	Here's Why You Should Retain Glaukos (GKOS) Stock for Now (Zacks)
May-28-24 07:00AM	Glaukos Announces Participation in Upcoming Investor Conferences (Business Wire)
May-14-24 04:47PM	Glaukos Insider Sold Shares Worth $264,791, According to a Recent SEC Filing (MT Newswires)
12:20PM	Glaukos (GKOS) Reaches 52-Week High: What's Aiding the Stock? (Zacks)
May-02-24 12:01PM	Needham Adjusts Price Target on Glaukos to $113 From $108, Maintains Buy Rating (MT Newswires) +6.19%
11:59AM	JPMorgan Adjusts Price Target on Glaukos to $110 From $108, Maintains Overweight Rating (MT Newswires)
09:14AM	Glaukos (GKOS) Q1 Earnings Miss Estimates, Revenues Up Y/Y (Zacks)
07:12AM	Q1 2024 Glaukos Corp Earnings Call (Thomson Reuters StreetEvents)
03:38AM	Glaukos Corp (GKOS) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic ... (GuruFocus.com)
May-01-24 11:53PM	GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:50PM	Loading…
05:50PM	Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:35PM	Glaukos Corp (GKOS) Q1 2024 Earnings: Misses Analyst EPS Forecast, Surpasses Revenue Expectations (GuruFocus.com)
04:50PM	Glaukos: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Glaukos Announces First Quarter 2024 Financial Results (Business Wire)
Apr-16-24 04:05PM	Glaukos Announces the Release of its 2023 Sustainability Report (Business Wire)
Apr-15-24 08:19AM	Here's Why You Should Retain Glaukos (GKOS) Stock for Now (Zacks)
Apr-12-24 09:22AM	Glaukos (GKOS) Gains Nearly 25% YTD: What's Driving the Rally? (Zacks)
Apr-10-24 07:00AM	Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1 (Business Wire)
Apr-08-24 10:41AM	Glaukos (GKOS) Hits 52-Week High: What's Driving the Stock? (Zacks)
Apr-04-24 12:02PM	Glaukos' (GKOS) iDose TR Receives Permanent J- Code From CMS (Zacks)
Apr-03-24 07:00AM	Glaukos Receives Permanent J-code for iDose TR (travoprost intracameral implant) (Business Wire) +5.40%
Apr-01-24 07:00AM	Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting (Business Wire)
Mar-22-24 11:30AM	Glaukos (GKOS) Down 4.3% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-13-24 07:56AM	Here's Why You Should Retain Glaukos (GKOS) Stock for Now (Zacks)
Feb-27-24 02:03AM	Glaukos Corp Director Mark Foley Sells 4,560 Shares (GuruFocus.com)
Feb-22-24 10:16AM	Glaukos Corporation (NYSE:GKOS) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:58AM	Glaukos (GKOS) Q4 Earnings Miss Estimates, Revenues Rise Y/Y (Zacks)
07:47AM	Q4 2023 Glaukos Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-21-24 05:20PM	Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:35PM	Glaukos Corp (GKOS) Reports Increased Sales but Widening Losses in Q4 and Full Year 2023 (GuruFocus.com)
04:17PM	Glaukos: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-15-24 02:04AM	Insider Sell: Glaukos Corp's President & COO Joseph Gilliam Sells 1,512 Shares (GuruFocus.com)
Feb-14-24 10:00AM	Glaukos (GKOS) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
08:15AM	Here's Why You Should Retain Glaukos (GKOS) Stock for Now (Zacks)
Feb-01-24 03:01PM	Glaukos Corp's President & COO Joseph Gilliam Sells 9,476 Shares (GuruFocus.com)
Jan-31-24 07:00AM	Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21 (Business Wire)
Jan-30-24 10:42AM	Glaukos (GKOS) Hits 52-Week High: What's Driving the Stock? (Zacks)
Jan-18-24 07:57PM	Glaukos Corp Insider Sells Company Shares (GuruFocus.com)
Jan-16-24 07:41AM	Here's Why You Should Retain Glaukos (GKOS) Stock for Now (Zacks)
Jan-11-24 11:26AM	Glaukos' (GKOS) Preliminary Q4 Revenues Ride on Product Demand (Zacks)
Jan-09-24 07:00AM	Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance (Business Wire) +5.55%
Dec-23-23 01:01AM	Glaukos Corp President & COO Joseph Gilliam Sells 25,000 Shares (GuruFocus.com)
Dec-21-23 01:31AM	Spotify, Salesforce shares gain following upgrades: 4 big analyst picks (Investing.com) +6.92%
Dec-20-23 07:00AM	Glaukos Announces Participation in the J.P. Morgan Healthcare Conference (Business Wire)
Dec-19-23 01:28PM	Glaukos' (GKOS) iDose TR Gets FDA Nod for Glaucoma Treatment (Zacks)
Dec-18-23 09:49AM	Glaukos (GKOS) Hits 52-Week High: What's Aiding the Stock? (Zacks)
Dec-15-23 05:57AM	Glaukos wins FDA approval for drug-releasing eye implant to treat glaucoma (MedTech Dive) +7.58%
Dec-14-23 07:45AM	Here's Why You Should Retain Glaukos (GKOS) Stock for Now (Zacks) +25.36%
07:00AM	Glaukos Announces FDA Approval of iDose TR (travoprost intracameral implant) (Business Wire)
Dec-03-23 10:30AM	Bearish Bets: 3 Stocks You Definitely Should Think About Shorting This Week (TheStreet.com)
Dec-01-23 11:31AM	Why Is Glaukos (GKOS) Down 0.4% Since Last Earnings Report? (Zacks)
Nov-15-23 08:00AM	Here's Why You Should Retain Glaukos (GKOS) Stock for Now (Zacks)
Nov-07-23 07:00AM	Glaukos Announces Participation in Stifel Healthcare Conference (Business Wire)
Nov-02-23 06:17PM	Glaukos Corporation (NYSE:GKOS) Q3 2023 Earnings Call Transcript (Insider Monkey) -7.58%
10:34AM	Glaukos (GKOS) Q3 Earnings Beat Estimates, Revenues Rise Y/Y (Zacks)
Nov-01-23 07:00PM	Glaukos (GKOS) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:07PM	Glaukos Corp (GKOS) Reports 10% Increase in Q3 2023 Net Sales (GuruFocus.com)
04:57PM	Glaukos: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Glaukos Announces Third Quarter 2023 Financial Results (Business Wire)
Oct-31-23 07:33AM	Medical Device Stocks to Watch for Earnings on Nov 1: MCK & More (Zacks)
07:00AM	Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Academy of Ophthalmology Annual Meeting (Business Wire)
Oct-11-23 07:00AM	Glaukos to Release Third Quarter 2023 Financial Results after Market Close on November 1, 2023 (Business Wire)
Oct-05-23 07:53AM	Here's Why You Should Retain Glaukos (GKOS) Stock for Now (Zacks)
Sep-19-23 06:20AM	Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)? (Zacks)
Aug-23-23 07:00AM	Glaukos Announces Participation in Wells Fargo Healthcare Conference (Business Wire)
Aug-03-23 11:16AM	Glaukos (GKOS) Q2 Earnings Beat Estimates, Revenues Rise Y/Y (Zacks)
Aug-02-23 10:00PM	Compared to Estimates, Glaukos (GKOS) Q2 Earnings: A Look at Key Metrics (Zacks)
06:05PM	Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:58PM	Glaukos: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Glaukos Announces Second Quarter 2023 Financial Results (Business Wire)
Aug-01-23 09:02AM	Medical Device Aug 2 Earnings Roster: MCK, FMS & GKOS (Zacks)
Jul-31-23 06:05PM	OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-20-23 07:19AM	Here's Why You Should Retain Glaukos (GKOS) in Your Portfolio (Zacks)
Jul-19-23 12:43PM	Glaukos' (GKOS) New Tie-Up to Address Chronic Eye Disease (Zacks)
Jul-17-23 07:00AM	Glaukos Enters into a Collaboration and Marketing Agreement with Radius XR, Inc. (Business Wire)
Jul-14-23 06:22PM	These 2 Soaring Stocks Finished the Week Strong (Motley Fool) +10.40%
08:38AM	Glaukos (GKOS) Stock Hits 52-Week High: More Room to Grow? (Zacks)
Jul-12-23 07:00AM	Glaukos to Release Second Quarter 2023 Financial Results after Market Close on August 2, 2023 (Business Wire)
Jun-21-23 08:00PM	GKOS: Lowering target price to $58.00 (Argus Research)

Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kliman Gilbert H	Director	Sep 09 '24	Option Exercise	32.00	3,000	96,000	35,336	Sep 11 07:49 PM
Kliman Gilbert H	Director	Sep 09 '24	Sale	130.67	3,000	392,000	32,336	Sep 11 07:49 PM
Kliman Gilbert H	Director	Sep 09 '24	Proposed Sale	130.67	3,000	392,000		Sep 09 03:03 PM
Gilliam Joseph E	PRESIDENT & COO	Aug 21 '24	Option Exercise	55.18	5,000	275,900	107,169	Aug 23 05:25 PM
Gilliam Joseph E	PRESIDENT & COO	Aug 21 '24	Sale	129.36	5,000	646,791	102,169	Aug 23 05:25 PM
Gilliam Joseph E	Officer	Aug 21 '24	Proposed Sale	129.36	5,000	646,803		Aug 21 04:19 PM
Stapley Marc	Director	Aug 15 '24	Option Exercise	32.00	6,250	200,000	40,326	Aug 19 05:15 PM
Stapley Marc	Director	Aug 15 '24	Sale	125.93	6,250	787,086	34,076	Aug 19 05:15 PM
Stapley Marc	Director	Aug 15 '24	Proposed Sale	125.93	6,250	787,074		Aug 15 05:12 PM
WEISNER AIMEE S	Director	Aug 08 '24	Option Exercise	32.00	25,000	800,000	55,119	Aug 12 05:05 PM
WEISNER AIMEE S	Director	Aug 08 '24	Sale	120.00	25,000	3,000,000	30,119	Aug 12 05:05 PM
WEISNER AIMEE S	Director	Aug 08 '24	Proposed Sale	120.00	25,000	3,000,000		Aug 08 12:15 PM
Gilliam Joseph E	PRESIDENT & COO	Jul 05 '24	Option Exercise	69.30	2,250	155,925	104,095	Jul 09 05:10 PM
Gilliam Joseph E	PRESIDENT & COO	Jul 05 '24	Sale	121.39	2,250	273,128	101,845	Jul 09 05:10 PM
Gilliam Joseph E	PRESIDENT & COO	Jun 03 '24	Option Exercise	55.18	2,500	137,950	104,345	Jun 05 07:35 PM
Gilliam Joseph E	PRESIDENT & COO	Jun 03 '24	Sale	113.50	2,500	283,751	101,845	Jun 05 07:35 PM
Kliman Gilbert H	Director	May 30 '24	Option Exercise	32.00	5,000	160,000	35,620	Jun 03 09:00 PM
Kliman Gilbert H	Director	May 30 '24	Sale	112.00	5,000	560,000	30,620	Jun 03 09:00 PM
Stapley Marc	Director	May 15 '24	Option Exercise	32.00	6,250	200,000	38,610	May 16 07:45 PM
Stapley Marc	Director	May 15 '24	Sale	112.80	6,250	704,993	32,360	May 16 07:45 PM
Gilliam Joseph E	PRESIDENT & COO	May 10 '24	Option Exercise	55.18	2,395	132,156	104,240	May 14 04:43 PM
Gilliam Joseph E	PRESIDENT & COO	May 10 '24	Sale	110.56	2,395	264,791	101,845	May 14 04:43 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	May 10 '24	Sale	110.51	353	39,011	51,647	May 14 04:41 PM
Gilliam Joseph E	PRESIDENT & COO	May 06 '24	Option Exercise	55.18	105	5,794	101,950	May 08 05:21 PM
Gilliam Joseph E	PRESIDENT & COO	May 06 '24	Sale	110.36	105	11,588	101,845	May 08 05:21 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	May 06 '24	Sale	110.26	90	9,923	52,000	May 08 05:08 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	May 02 '24	Sale	105.69	442	46,713	52,090	May 06 05:27 PM
Gilliam Joseph E	PRESIDENT & COO	May 02 '24	Option Exercise	69.30	2,059	142,689	103,904	May 06 05:23 PM
Gilliam Joseph E	PRESIDENT & COO	May 02 '24	Sale	105.52	2,059	217,263	101,845	May 06 05:23 PM
Hoffmeister David F	Director	Apr 10 '24	Option Exercise	7.28	10,000	72,750	15,767	Apr 12 07:49 PM
Gilliam Joseph E	PRESIDENT & COO	Apr 08 '24	Option Exercise	41.69	59,801	2,493,104	161,646	Apr 10 08:20 PM
Gilliam Joseph E	PRESIDENT & COO	Apr 08 '24	Sale	100.47	59,801	6,008,359	101,845	Apr 10 08:20 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	Apr 08 '24	Sale	100.54	1,372	137,944	52,532	Apr 09 07:46 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	Apr 05 '24	Sale	96.63	262	25,316	53,904	Apr 09 07:46 PM
Gilliam Joseph E	PRESIDENT & COO	Apr 05 '24	Option Exercise	55.18	2,457	135,577	104,302	Apr 09 07:40 PM
Gilliam Joseph E	PRESIDENT & COO	Apr 05 '24	Sale	96.81	2,457	237,862	101,845	Apr 09 07:40 PM
Gilliam Joseph E	PRESIDENT & COO	Apr 03 '24	Option Exercise	55.18	200	11,036	102,045	Apr 05 06:15 PM
Gilliam Joseph E	PRESIDENT & COO	Apr 04 '24	Option Exercise	55.18	200	11,036	102,045	Apr 05 06:15 PM
Gilliam Joseph E	PRESIDENT & COO	Apr 03 '24	Sale	96.61	200	19,322	101,845	Apr 05 06:15 PM
Gilliam Joseph E	PRESIDENT & COO	Apr 04 '24	Sale	96.57	200	19,314	101,845	Apr 05 06:15 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	Apr 04 '24	Sale	95.33	434	41,371	54,166	Apr 05 06:13 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	Apr 03 '24	Sale	94.62	316	29,900	54,600	Apr 05 06:13 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	Apr 02 '24	Sale	90.37	474	42,835	54,916	Apr 03 08:32 PM
Kliman Gilbert H	Director	Mar 07 '24	Option Exercise	32.00	5,000	160,000	35,620	Mar 08 05:12 PM
Kliman Gilbert H	Director	Mar 06 '24	Sale	85.34	8,347	712,307	0	Mar 08 05:12 PM
Kliman Gilbert H	Director	Mar 07 '24	Sale	88.25	5,000	441,250	30,620	Mar 08 05:12 PM
Stapley Marc	Director	Feb 29 '24	Option Exercise	32.00	6,250	200,000	38,610	Mar 04 08:09 PM
Stapley Marc	Director	Feb 29 '24	Sale	90.09	6,250	563,087	32,360	Mar 04 08:09 PM
Kliman Gilbert H	Director	Feb 27 '24	Sale	92.00	8,000	736,000	8,347	Feb 29 05:52 PM
Gilliam Joseph E	PRESIDENT & COO	Feb 23 '24	Option Exercise	39.82	118,831	4,731,666	238,633	Feb 27 09:29 PM
Gilliam Joseph E	PRESIDENT & COO	Feb 23 '24	Sale	92.14	140,245	12,922,002	98,388	Feb 27 09:29 PM
Foley Mark J	Director	Feb 23 '24	Option Exercise	7.28	10,000	72,750	37,780	Feb 26 07:01 PM
Foley Mark J	Director	Feb 23 '24	Sale	92.87	4,560	423,487	33,220	Feb 26 07:01 PM
Gilliam Joseph E	PRESIDENT & COO	Feb 12 '24	Option Exercise	55.18	1,512	83,432	121,314	Feb 14 04:56 PM
Gilliam Joseph E	PRESIDENT & COO	Feb 12 '24	Sale	96.80	1,512	146,362	119,802	Feb 14 04:56 PM
Gilliam Joseph E	PRESIDENT & COO	Feb 08 '24	Option Exercise	39.10	5,000	195,500	124,802	Feb 12 06:41 PM
Gilliam Joseph E	PRESIDENT & COO	Feb 09 '24	Option Exercise	55.18	631	34,819	120,433	Feb 12 06:41 PM
Gilliam Joseph E	PRESIDENT & COO	Feb 08 '24	Sale	96.07	5,000	480,350	119,802	Feb 12 06:41 PM
Gilliam Joseph E	PRESIDENT & COO	Feb 09 '24	Sale	96.70	631	61,018	119,802	Feb 12 06:41 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	Feb 08 '24	Sale	95.78	550	52,682	54,035	Feb 09 06:33 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	Feb 07 '24	Sale	95.00	33	3,135	54,585	Feb 09 06:33 PM
Gilliam Joseph E	PRESIDENT & COO	Jan 29 '24	Option Exercise	39.10	9,476	370,512	129,278	Jan 31 05:35 PM
Gilliam Joseph E	PRESIDENT & COO	Jan 29 '24	Sale	94.12	9,476	891,881	119,802	Jan 31 05:35 PM
Gilliam Joseph E	PRESIDENT & COO	Jan 22 '24	Option Exercise	39.10	524	20,488	120,326	Jan 24 06:04 PM
Gilliam Joseph E	PRESIDENT & COO	Jan 22 '24	Sale	94.01	524	49,261	119,802	Jan 24 06:04 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	Jan 18 '24	Sale	90.54	583	52,784	54,618	Jan 22 05:30 PM
Gilliam Joseph E	PRESIDENT & COO	Jan 16 '24	Option Exercise	30.92	4,890	151,199	124,692	Jan 18 05:30 PM
Gilliam Joseph E	PRESIDENT & COO	Jan 16 '24	Sale	89.17	4,890	436,041	119,802	Jan 18 05:30 PM
Gilliam Joseph E	PRESIDENT & COO	Jan 12 '24	Option Exercise	30.92	110	3,401	119,912	Jan 16 04:59 PM
Gilliam Joseph E	PRESIDENT & COO	Jan 12 '24	Sale	89.01	110	9,791	119,802	Jan 16 04:59 PM
Burns Thomas William	CHAIRMAN & CEO	Jan 08 '24	Option Exercise	7.28	60,000	436,500	115,835	Jan 10 07:14 PM
Burns Thomas William	CHAIRMAN & CEO	Jan 09 '24	Option Exercise	7.28	115	837	55,950	Jan 10 07:14 PM
Burns Thomas William	CHAIRMAN & CEO	Jan 08 '24	Sale	82.55	60,000	4,952,706	55,835	Jan 10 07:14 PM
Burns Thomas William	CHAIRMAN & CEO	Jan 09 '24	Sale	86.85	115	9,988	55,835	Jan 10 07:14 PM
Burns Thomas William	CHAIRMAN & CEO	Jan 02 '24	Option Exercise	7.28	95,000	691,125	150,835	Jan 03 06:18 PM
Burns Thomas William	CHAIRMAN & CEO	Jan 02 '24	Sale	77.20	95,000	7,334,253	55,835	Jan 03 06:18 PM
Gilliam Joseph E	PRESIDENT & COO	Dec 21 '23	Option Exercise	41.69	25,000	1,042,250	145,001	Dec 22 06:05 PM
Gilliam Joseph E	PRESIDENT & COO	Dec 21 '23	Sale	84.80	25,000	2,120,062	120,001	Dec 22 06:05 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	Dec 21 '23	Sale	85.14	583	49,637	55,242	Dec 22 06:04 PM
Burns Thomas William	CHAIRMAN & CEO	Dec 21 '23	Option Exercise	7.28	79,684	579,701	135,519	Dec 22 06:03 PM
Burns Thomas William	CHAIRMAN & CEO	Dec 22 '23	Option Exercise	7.28	1	7	55,836	Dec 22 06:03 PM
Burns Thomas William	CHAIRMAN & CEO	Dec 21 '23	Sale	85.21	79,684	6,789,874	55,835	Dec 22 06:03 PM
Burns Thomas William	CHAIRMAN & CEO	Dec 22 '23	Sale	85.32	1	85	55,835	Dec 22 06:03 PM
Thurman Alex R.	SVP & CHIEF FINANCIAL OFFICER	Dec 15 '23	Sale	79.80	1,270	101,346	55,825	Dec 18 08:41 PM
Stapley Marc	Director	Dec 14 '23	Option Exercise	16.78	16,250	272,750	47,566	Dec 18 08:40 PM
Stapley Marc	Director	Dec 14 '23	Sale	75.93	16,250	1,233,875	31,316	Dec 18 08:40 PM
Burns Thomas William	CHAIRMAN & CEO	Dec 15 '23	Option Exercise	7.28	60,000	436,500	115,835	Dec 18 08:39 PM
Burns Thomas William	CHAIRMAN & CEO	Dec 14 '23	Option Exercise	7.28	30,000	218,250	85,835	Dec 18 08:39 PM
Burns Thomas William	CHAIRMAN & CEO	Dec 15 '23	Sale	80.94	60,000	4,856,448	55,835	Dec 18 08:39 PM
Burns Thomas William	CHAIRMAN & CEO	Dec 14 '23	Sale	75.91	30,000	2,277,357	55,835	Dec 18 08:39 PM
Burns Thomas William	CHAIRMAN & CEO	Oct 02 '23	Option Exercise	7.28	45,000	327,375	99,785	Oct 04 05:50 PM
Burns Thomas William	CHAIRMAN & CEO	Oct 02 '23	Sale	71.98	45,000	3,239,262	54,785	Oct 04 05:50 PM

Open in Screener

STAA

Staar Surgical Co.

Sep 20 • 04:00PM ET

30.39

Dollar change -1.21
Percentage change -3.83	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

STAA Staar Surgical Co. daily Stock Chart

Held by: IJR VTI IWM VB VXF VBK SPSM IWO IJT SCHA

Index	RUT	P/E	90.72	EPS (ttm)	0.34	Insider Own	0.82%	Shs Outstand	48.84M	Perf Week	-6.15%
Market Cap	1.49B	Forward P/E	39.63	EPS next Y	0.77	Insider Trans	0.33%	Shs Float	48.78M	Perf Month	-14.83%
Income	16.61M	PEG	3.02	EPS next Q	0.18	Inst Own	92.11%	Short Float	8.48%	Perf Quarter	-25.42%
Sales	332.94M	P/S	4.49	EPS this Y	-28.68%	Inst Trans	2.21%	Short Ratio	5.26	Perf Half Y	-22.04%
Book/sh	8.32	P/B	3.65	EPS next Y	6.46%	ROA	3.49%	Short Interest	4.14M	Perf Year	-25.28%
Cash/sh	4.78	P/C	6.36	EPS next 5Y	30.00%	ROE	4.36%	52W Range	26.66 - 52.68	Perf YTD	-2.63%
Dividend Est.	-	P/FCF	110.32	EPS past 5Y	31.51%	ROI	3.77%	52W High	-42.31%	Beta	0.59
Dividend TTM	-	Quick Ratio	5.21	Sales past 5Y	21.55%	Gross Margin	79.24%	52W Low	14.01%	ATR (14)	1.74
Dividend Ex-Date	-	Current Ratio	5.80	EPS Y/Y TTM	-34.15%	Oper. Margin	7.90%	RSI (14)	38.22	Volatility	5.77% 4.80%
Employees	1115	Debt/Eq	0.09	Sales Y/Y TTM	8.83%	Profit Margin	4.99%	Recom	2.00	Target Price	49.20
Option/Short	Yes / Yes	LT Debt/Eq	0.08	EPS Q/Q	20.90%	Payout	0.00%	Rel Volume	1.83	Prev Close	31.60
Sales Surprise	3.98%	EPS Surprise	63.25%	Sales Q/Q	7.26%	Earnings	Aug 07 AMC	Avg Volume	786.46K	Price	30.39
SMA20	-4.28%	SMA50	-17.60%	SMA200	-19.06%	Trades		Volume	1,436,855	Change	-3.83%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-15-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$50 → $37
Jun-11-24	Upgrade	BTIG Research	Neutral → Buy	$46
Mar-11-24	Upgrade	Stifel	Hold → Buy	$30 → $50
Dec-05-23	Downgrade	Needham	Buy → Hold
Dec-04-23	Initiated	Morgan Stanley	Equal-Weight	$35
Sep-15-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-03-23	Downgrade	Canaccord Genuity	Buy → Hold	$77 → $48
Jun-07-23	Downgrade	William Blair	Outperform → Mkt Perform
Apr-17-23	Initiated	Piper Sandler	Neutral	$65
Feb-06-23	Downgrade	BTIG Research	Buy → Neutral
Dec-28-22	Reiterated	BTIG Research	Buy	$80 → $67
Dec-08-22	Initiated	Stifel	Hold	$60
Nov-07-22	Upgrade	Sidoti	Neutral → Buy
Oct-14-22	Resumed	Stephens	Overweight	$91
Oct-13-22	Initiated	Mizuho	Buy	$85
Apr-08-22	Initiated	Needham	Buy	$87
Mar-28-22	Upgrade	The Benchmark Company	Hold → Buy	$97
Mar-18-22	Upgrade	BTIG Research	Neutral → Buy	$98
Jul-09-21	Initiated	Oppenheimer	Perform	$150
Jan-19-21	Downgrade	The Benchmark Company	Buy → Hold

Show Previous Ratings

Sep-17-24 08:00AM	Sidoti Events, LLC's Virtual September Small-Cap Conference (ACCESSWIRE)
Sep-16-24 12:00PM	Staar Surgical (STAA) Moves to Buy: Rationale Behind the Upgrade (Zacks)
Sep-06-24 01:01PM	Baillie Gifford Reduces Stake in Staar Surgical Co (GuruFocus.com)
Aug-13-24 10:48AM	Implied Volatility Surging for STAAR Surgical (STAA) Stock Options (Zacks)
Aug-12-24 09:15AM	Why Staar Surgical (STAA) International Revenue Trends Deserve Your Attention (Zacks)
11:53PM	Loading…
Aug-07-24 11:53PM	STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace) +11.03%
08:00PM	Staar Surgical (STAA) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:20PM	Staar Surgical (STAA) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:22PM	Staar Surgical: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports Second Quarter 2024 Results (Business Wire)
Jul-31-24 07:00AM	STAAR Surgical to Report Second Quarter Results on August 7, 2024 (Business Wire)
Jul-30-24 07:00AM	STAAR Surgical to Participate in Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jun-27-24 01:25PM	Staar Surgical Stock Earns RS Rating Upgrade (Investor's Business Daily)
04:01AM	Staar Surgical (STAA) Soars 7.5%: Is Further Upside Left in the Stock? (Zacks)
Jun-05-24 07:00AM	STAAR Surgical to Participate in Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
11:06AM	Loading…
May-13-24 11:06AM	Don't Overlook Staar Surgical (STAA) International Revenue Trends While Assessing the Stock (Zacks)
May-08-24 11:06AM	STAAR Surgical Company (NASDAQ:STAA) Q1 2024 Earnings Call Transcript (Insider Monkey) -12.07%
10:17AM	Mizuho Adjusts STAAR Surgical's Price Target to $55 From $53, Keeps Buy Rating (MT Newswires)
07:59AM	Morgan Stanley Raises Price Target on STAAR Surgical to $50 From $35, Keeps Equalweight Rating (MT Newswires)
03:43AM	Staar Surgical Co (STAA) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth Amid ... (GuruFocus.com)
May-07-24 11:54PM	STAA Stock Earnings: Staar Surgical Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
07:30PM	Staar Surgical (STAA) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
05:58PM	Staar Surgical Co Reports Q1 2024 Results: Misses Earnings Projections Despite Revenue Growth (GuruFocus.com)
05:26PM	Staar Surgical: Q1 Earnings Snapshot (Associated Press Finance)
04:03PM	STAAR Surgical Reports First Quarter 2024 Results (Business Wire)
04:01PM	STAAR Surgical Announces Milestone Strategic Agreement in U.S. with IQ Laser Vision (Business Wire)
May-06-24 09:16AM	Wall Street's Insights Into Key Metrics Ahead of Staar Surgical (STAA) Q1 Earnings (Zacks)
May-01-24 07:00AM	STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel (Business Wire)
Apr-29-24 07:00AM	STAAR Surgical to Report First Quarter Results on May 7, 2024 (Business Wire)
Apr-25-24 03:43PM	Staar Surgical Stock Climbs The Leadership Ladder With Jump To 84 RS Rating (Investor's Business Daily)
09:15AM	Loading…
Apr-05-24 09:15AM	Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength? (Zacks) +6.97%
Apr-04-24 04:26PM	Staar Surgical, A Lasik Rival, Just Crushed Quarterly Views; But Is Its 2026 Target Too Aggressive? (Investor's Business Daily) +16.48%
03:54PM	Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus (Benzinga)
07:00AM	STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024 (Business Wire)
Apr-02-24 07:00AM	STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024 (Business Wire)
Mar-26-24 11:45AM	Nvidias Market Cap Myopia: 3 Stocks Proving Size Isnt Everything (InvestorPlace)
Mar-20-24 04:22AM	STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses (PR Newswire)
Mar-18-24 07:00AM	STAAR Surgical Celebrates Three Million Implantable Collamer Lenses (Business Wire)
Mar-12-24 10:30AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
07:00AM	STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors (Business Wire)
Mar-06-24 07:00AM	STAAR Surgical to Participate in Two Upcoming Investor Conferences (Business Wire) +6.67%
Feb-28-24 10:58AM	STAAR Surgical Company (NASDAQ:STAA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 02:00PM	Staar Surgical (STAA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
Feb-26-24 05:30PM	Staar Surgical (STAA) Beats Q4 Earnings Estimates (Zacks)
04:39PM	Staar Surgical: Q4 Earnings Snapshot (Associated Press Finance)
04:34PM	Staar Surgical Co (STAA) Posts Solid Growth in Q4 and FY 2023, Affirms Positive Outlook for 2024 (GuruFocus.com)
04:01PM	STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results (Business Wire)
Feb-19-24 07:00AM	STAAR Surgical to Report Fourth Quarter Results on February 26, 2024 (Business Wire)
Jan-27-24 01:03PM	Baillie Gifford Adjusts Position in Staar Surgical Co (GuruFocus.com)
Jan-23-24 07:00AM	STAAR Surgical Announces Strategic Agreement in U.S. with SharpeVision (Business Wire)
Jan-12-24 06:49PM	Howard Hughes, Carrier, and More Stocks See Action From Activist Investors (Barrons.com) -5.14%
Jan-08-24 07:00AM	STAAR Surgical Announces Preliminary Results for Fourth Quarter and Fiscal 2023 (Business Wire) +11.52%
Dec-17-23 12:35PM	7 Stocks with Strong Insider Buying: December 2023 (InvestorPlace)
Dec-05-23 03:16AM	Lululemon Athletica gets one more downgrade ahead of Q3 report: 4 big analyst cuts (Investing.com)
Dec-04-23 04:05PM	Lilian Zhou Appointed to STAAR Surgical Board of Directors (Business Wire)
Nov-15-23 07:00AM	STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023) (Business Wire)
Nov-02-23 05:50PM	STAAR Surgical Company (NASDAQ:STAA) Q3 2023 Earnings Call Transcript (Insider Monkey) -16.87%
09:23AM	Q3 2023 STAAR Surgical Co Earnings Call (Thomson Reuters StreetEvents)
Nov-01-23 06:30PM	Here's What Key Metrics Tell Us About Staar Surgical (STAA) Q3 Earnings (Zacks)
05:56PM	Staar Surgical Co (STAA) Reports 6% Y/Y Increase in Q3 2023 Net Sales (GuruFocus.com)
04:17PM	Staar Surgical: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	STAAR Surgical Reports Third Quarter 2023 Results (Business Wire)
Oct-31-23 04:40PM	Investor urges STAAR Surgical to spin off Asia unit - letter (Reuters)
Oct-18-23 04:05PM	STAAR Surgical to Report Third Quarter Results on November 1, 2023 (Business Wire)
Oct-17-23 07:00AM	STAAR Surgical Celebrates 30th Anniversary of Implantable Collamer Lens (ICL) (Business Wire)
Oct-13-23 06:30PM	Staar Surgical, Howard Hughes Holdings, and More Stocks See Action From Activist Investors (Barrons.com) +6.01%
Oct-10-23 10:51AM	Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL (PR Newswire)
Sep-19-23 11:51AM	Is Staar Surgical Co (STAA) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
Sep-15-23 09:32AM	Shake Shack upgraded, DoorDash downgraded: Wall Street's top analyst calls (The Fly)
Sep-14-23 12:53PM	Is Staar Surgical Co (STAA) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
07:00AM	STAAR Surgical to Ring Nasdaq Stock Market Closing Bell Following Vision 2026 Investor Day on September 14, 2023 (Business Wire)
Sep-08-23 11:38AM	Staar Surgical Co (STAA): A Potential Value Trap? (GuruFocus.com)
Sep-07-23 05:00PM	STAAR Surgical to Host "Vision 2026" Investor Day on September 14, 2023 (Business Wire)
Aug-18-23 10:40AM	Dolby Labs jumps as S&P prepares to add it to its MidCap 400 index (Investing.com)
Aug-17-23 06:48PM	Dolby Laboratories Set to Join S&P MidCap 400; Staar Surgical to Join S&P SmallCap 600 (PR Newswire)
Aug-09-23 07:00AM	STAAR Surgical Teams Up With Tennessee Titans Quarterback Will Levis On Life Changing Vision Correction Procedure, EVO ICL (Business Wire)
Aug-07-23 07:00AM	STAAR Surgical to Participate in Upcoming Investor Conferences (Business Wire)
05:00AM	3 Strong Buy Growth Stocks You Should Be Loading Up On Now (InvestorPlace)
Aug-03-23 07:18PM	Why STAAR Surgical Stock Dropped Today (Motley Fool) -9.60%
Aug-02-23 05:25PM	Staar Surgical (STAA) Q2 Earnings Beat Estimates (Zacks)
04:21PM	Staar Surgical: Q2 Earnings Snapshot (AP Finance)
04:01PM	STAAR Surgical Reports Second Quarter 2023 Results (Business Wire)
Jul-19-23 07:00AM	STAAR Surgical to Report Second Quarter Results on August 2, 2023 (Business Wire)
Jun-21-23 08:00PM	STAA: Rating increased to a HOLD (Argus Research)
Jun-13-23 08:00AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
May-26-23 06:00AM	STAAR Surgical Company (NASDAQ:STAA) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? (Simply Wall St.)
May-17-23 10:10AM	2 Stocks With Unstoppable Growth Potential for the Next Decade (Motley Fool)
May-09-23 01:48PM	STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue (Simply Wall St.)
May-04-23 07:00AM	EVO ICL Sponsors Jonas Brothers The Tour (Business Wire) -7.78%
May-03-23 05:35PM	Staar Surgical (STAA) Beats Q1 Earnings and Revenue Estimates (Zacks)
04:29PM	Staar Surgical: Q1 Earnings Snapshot (AP Finance)
04:01PM	STAAR Surgical Reports First Quarter 2023 Results (Business Wire)
Apr-27-23 10:02AM	Cardinal Health (CAH) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-26-23 08:00PM	STAA: Lowering target price to $54.00 (Argus Research)
10:02AM	Earnings Preview: Staar Surgical (STAA) Q1 Earnings Expected to Decline (Zacks)
Apr-23-23 08:25AM	Should You Think About Buying STAAR Surgical Company (NASDAQ:STAA) Now? (Simply Wall St.)
Apr-19-23 07:00AM	STAAR Surgical to Report First Quarter Results on May 3, 2023 (Business Wire)
Apr-07-23 11:44AM	STAAR Surgical's (NASDAQ:STAA) investors will be pleased with their incredible 346% return over the last five years (Simply Wall St.)
Apr-04-23 06:00PM	Staar Surgical (STAA) Gains As Market Dips: What You Should Know (Zacks)
Mar-29-23 06:00PM	Staar Surgical (STAA) Stock Sinks As Market Gains: What You Should Know (Zacks)

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Butcher Arthur C	Director	Aug 12 '24	Buy	37.99	1,315	49,957	4,208	Aug 19 05:31 PM
BROADWOOD PARTNERS, L.P.	10% Owner	May 09 '24	Buy	42.56	1	43	10,768,431	May 13 06:00 PM
WEISNER AIMEE S	Director	Mar 14 '24	Buy	38.11	1,750	66,692	10,864	Mar 14 05:23 PM
Williams Patrick F.	Chief Financial Officer	Mar 07 '24	Option Exercise	0.00	2,614	0	45,475	Mar 11 06:06 AM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 08 '24	Buy	27.11	4,042	109,570	10,768,430	Jan 10 05:44 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 05 '24	Buy	28.48	156,734	4,463,231	10,764,388	Jan 05 07:07 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 04 '24	Buy	28.91	63,246	1,828,183	10,607,654	Jan 05 07:07 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Jan 03 '24	Buy	28.93	6,573	190,144	10,544,408	Jan 05 07:07 PM
Zhou Lilian Yansheng	Director	Dec 06 '23	Buy	30.74	850	26,129	2,327	Dec 06 04:11 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 30 '23	Buy	31.42	177,707	5,583,678	10,537,835	Nov 30 07:08 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 29 '23	Buy	31.39	160,300	5,031,358	10,360,128	Nov 30 07:08 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 28 '23	Buy	31.85	96,984	3,088,794	10,199,828	Nov 30 07:08 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 10 '23	Buy	32.73	34,320	1,123,383	10,102,337	Nov 14 07:13 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 13 '23	Buy	33.04	507	16,749	10,102,844	Nov 14 07:13 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 08 '23	Buy	33.71	139,409	4,699,073	9,928,017	Nov 09 07:01 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 09 '23	Buy	33.09	140,000	4,632,581	10,068,017	Nov 09 07:01 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 07 '23	Buy	34.03	9,731	331,127	9,788,608	Nov 09 07:01 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 06 '23	Buy	34.16	164,607	5,623,518	9,778,877	Nov 06 07:01 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 02 '23	Buy	35.79	144,027	5,155,243	9,613,750	Nov 06 07:01 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Nov 03 '23	Buy	36.06	520	18,753	9,614,270	Nov 06 07:01 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Oct 05 '23	Buy	37.92	97,474	3,696,399	9,394,424	Oct 06 07:43 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Oct 06 '23	Buy	37.62	75,299	2,832,417	9,469,723	Oct 06 07:43 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Oct 04 '23	Buy	37.93	32,523	1,233,649	9,296,950	Oct 06 07:43 PM
Lin Elizabeth Yeu	Director	Sep 21 '23	Buy	40.00	2,500	100,000	2,855	Sep 22 07:18 PM
BROADWOOD PARTNERS, L.P.	10% Owner	Sep 21 '23	Buy	39.62	154,814	6,133,467	9,264,427	Sep 21 08:31 PM

Open in Screener

LNSR

LENSAR Inc

Sep 20 • 04:00PM ET

4.45

Dollar change +0.14
Percentage change 3.25	%

Healthcare • Medical Devices • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VXF DFAT DFAS IWC DFAC DFSU DFUS DCOR

Index	-	P/E	-	EPS (ttm)	-1.11	Insider Own	21.41%	Shs Outstand	11.33M	Perf Week	-12.06%
Market Cap	51.66M	Forward P/E	-	EPS next Y	-0.81	Insider Trans	0.22%	Shs Float	9.12M	Perf Month	-0.67%
Income	-12.56M	PEG	-	EPS next Q	-0.29	Inst Own	41.84%	Short Float	0.76%	Perf Quarter	0.68%
Sales	45.12M	P/S	1.15	EPS this Y	-16.23%	Inst Trans	-0.46%	Short Ratio	2.73	Perf Half Y	21.92%
Book/sh	2.05	P/B	2.17	EPS next Y	46.67%	ROA	-18.94%	Short Interest	0.07M	Perf Year	39.50%
Cash/sh	1.22	P/C	3.64	EPS next 5Y	-	ROE	-29.95%	52W Range	1.80 - 5.60	Perf YTD	26.78%
Dividend Est.	-	P/FCF	-	EPS past 5Y	0.14%	ROI	-32.29%	52W High	-20.53%	Beta	0.64
Dividend TTM	-	Quick Ratio	2.15	Sales past 5Y	12.81%	Gross Margin	47.54%	52W Low	147.22%	ATR (14)	0.40
Dividend Ex-Date	-	Current Ratio	3.88	EPS Y/Y TTM	40.31%	Oper. Margin	-20.84%	RSI (14)	47.84	Volatility	12.46% 8.36%
Employees	130	Debt/Eq	0.05	Sales Y/Y TTM	17.99%	Profit Margin	-27.83%	Recom	1.00	Target Price	8.00
Option/Short	Yes / Yes	LT Debt/Eq	0.04	EPS Q/Q	2.39%	Payout	-	Rel Volume	0.54	Prev Close	4.31
Sales Surprise	4.00%	EPS Surprise	-166.71%	Sales Q/Q	5.19%	Earnings	Aug 08 BMO	Avg Volume	25.34K	Price	4.45
SMA20	-2.93%	SMA50	-4.93%	SMA200	10.06%	Trades		Volume	13,704	Change	3.25%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-24-21	Initiated	SVB Leerink	Outperform	$20

Sep-04-24 04:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:00AM	LENSAR to Participate in Two Upcoming Investor Conferences (Business Wire)
Aug-08-24 07:00AM	LENSAR Reports Second Quarter 2024 Results and Provides Business Update (Business Wire) -9.93%
Aug-07-24 07:00AM	LENSAR Announces Certification for the ALLY Adaptive Cataract Treatment System in the European Union (Business Wire) -7.90%
Aug-01-24 06:42PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
07:00AM	Loading…
07:00AM	LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 (Business Wire)
Jul-05-24 10:00AM	3 Under-$10 Stocks With the Potential to Make You a Millionaire (InvestorPlace)
Jul-02-24 05:50PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.80%
Jun-03-24 06:34PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -7.33%
May-23-24 08:00AM	LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference (Business Wire)
May-13-24 11:14AM	LENSAR, Inc. (NASDAQ:LNSR) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 11:57AM	LNSR Stock Earnings: LENSAR Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +12.68%
07:00AM	LENSAR Reports First Quarter 2024 Results and Provides Business Update (Business Wire)
May-02-24 08:00AM	LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 (Business Wire)
May-01-24 06:38PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
06:28PM	Loading…
Apr-01-24 06:28PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-05-24 09:11AM	LENSAR, Inc. (NASDAQ:LNSR) Q4 2023 Earnings Call Transcript (Insider Monkey) -10.97%
Mar-04-24 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update (Business Wire)
Mar-01-24 05:01PM	LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-26-24 08:00AM	LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024 (Business Wire)
Nov-12-23 09:38AM	LENSAR, Inc. (NASDAQ:LNSR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 07:00AM	LENSAR Reports Third Quarter 2023 Results and Provides Business Update (Business Wire) +12.44%
Nov-02-23 08:03AM	LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023 (Business Wire) +5.12%
Aug-09-23 07:00AM	LENSAR Reports Second Quarter 2023 Results and Provides Business Update (Business Wire) +12.73%
Jul-24-23 07:00AM	LENSAR® Reports Adoption of ALLY® System in Multi-Center Ophthalmology Groups (Business Wire)
May-15-23 07:00AM	LENSAR Reports First Quarter 2023 Results and Provides Business Update (Business Wire) -9.45%
May-10-23 08:00AM	LENSAR to Report First Quarter 2023 Financial Results on Monday, May 15, 2023 (Business Wire)
Mar-20-23 03:05AM	LENSAR, Inc. (NASDAQ:LNSR) Q4 2022 Earnings Call Transcript (Insider Monkey) -10.98%
Mar-16-23 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update (Business Wire)
Mar-09-23 08:00AM	LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023 (Business Wire)
07:00AM	Loading…
Feb-14-23 07:00AM	LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results (Business Wire)
Nov-22-22 08:00AM	LENSAR to Present at Two Upcoming Investor Conferences (Business Wire)
Nov-09-22 07:00AM	LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update (Business Wire) -11.56%
Nov-02-22 08:00AM	LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022 (Business Wire)
Sep-08-22 07:00AM	LENSAR Announces Application for Certification of the ALLY Adaptive Cataract Treatment System in the EU (Business Wire)
Aug-16-22 07:00AM	First Patients Treated with LENSARs® ALLY Adaptive Cataract Treatment System (Business Wire)
Aug-08-22 07:00AM	LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Aug-01-22 08:00AM	LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022 (Business Wire)
Jun-13-22 07:00AM	LENSAR® Receives U.S. FDA Clearance of ALLY Adaptive Cataract Treatment System (Business Wire)
Jun-09-22 07:30AM	Shareholders in LENSAR (NASDAQ:LNSR) are in the red if they invested a year ago (Simply Wall St.)
May-09-22 07:00AM	LENSAR Reports First Quarter 2022 Financial Results and Provides Business Update (Business Wire)
May-02-22 08:00AM	LENSAR to Report First Quarter 2022 Financial Results on Monday, May 9, 2022 (Business Wire)
Apr-21-22 09:08AM	We're Not Very Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Rate (Simply Wall St.)
Mar-03-22 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (Business Wire) +6.34%
Mar-01-22 07:00AM	LENSAR Announces U.S. Food and Drug Administration Acceptance of 510(k) Submission for ALLY (Business Wire)
Feb-28-22 04:01PM	LENSAR to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 3, 2022 (Business Wire)
Feb-23-22 02:01AM	Should Now Consider Selling Your LENSAR (LNSR) Shares? (Insider Monkey)
Feb-10-22 08:00AM	LENSAR to Participate in Two Upcoming Investor Conferences (Business Wire)
Jan-04-22 08:00AM	LENSAR to Present at the H.C. Wainwright Virtual BioConnect Conference (Business Wire)
Dec-31-21 07:53AM	Shareholders in LENSAR (NASDAQ:LNSR) are in the red if they invested a year ago (Simply Wall St.)
Nov-16-21 08:00AM	LENSAR to Present at Two Upcoming Investor Conferences (Business Wire)
Nov-12-21 07:00AM	LENSAR Announces Poster Presentations at the American Academy of Ophthalmology (Business Wire)
Nov-08-21 07:00AM	LENSAR Reports Third Quarter 2021 Financial Results and Provides Business Update (Business Wire)
Nov-01-21 08:00AM	LENSAR to Report Third Quarter 2021 Financial Results on Monday, November 8, 2021 (Business Wire)
Oct-02-21 10:32AM	We Think LENSAR (NASDAQ:LNSR) Can Afford To Drive Business Growth (Simply Wall St.)
Sep-02-21 08:00AM	LENSAR to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (Business Wire)
Aug-16-21 08:00AM	LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual Conference (Business Wire)
Aug-05-21 07:00AM	LENSAR Reports Second Quarter 2021 Financial Results and Provides Business Update (Business Wire)
Jul-29-21 08:00AM	LENSAR to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021 (Business Wire)
Jul-15-21 08:00AM	LENSAR Announces In-Person Demonstrations of Its Next Generation ALLY System and Multiple Data Presentations at the American Society of Cataract and Refractive Surgery (ASCRS) 2021 Annual Meeting (Business Wire)
May-24-21 08:00AM	LENSAR to Present at the Oppenheimer MedTech, Tools, & Diagnostics Summit (Business Wire)
May-05-21 07:00AM	LENSAR Reports First Quarter 2021 Financial Results and Provides Business Update (Business Wire)
06:45AM	LENSAR Inc to Host Earnings Call (ACCESSWIRE)
Apr-28-21 08:00AM	LENSAR to Hold First Quarter 2021 Financial Results Conference Call on Wednesday, May 5, 2021 (Business Wire)
Mar-10-21 07:00AM	LENSAR Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update (Business Wire) +5.58%
Mar-03-21 04:05PM	LENSAR to Hold Fourth Quarter and Full Year 2020 Financial Results and Business Update Conference Call on Wednesday, March 10, 2021 (Business Wire) -6.13%
Feb-16-21 01:28PM	Is LENSAR Inc. (LNSR) A Smart Long-Term Buy? (Insider Monkey)
Feb-08-21 08:00AM	LENSAR to Present at Two Upcoming Investor Conferences (Business Wire) +8.67%
Feb-01-21 07:00AM	LENSAR Expands Board of Directors with the Appointments of Aimee S. Weisner and Elizabeth G. OFarrell (Business Wire)
Jan-03-21 03:58AM	We Think LENSAR (NASDAQ:LNSR) Needs To Drive Business Growth Carefully (Simply Wall St.)
Nov-23-20 08:00AM	LENSAR to Present at the 32nd Annual Piper Sandler Virtual Healthcare Conference (Business Wire)
Nov-11-20 04:01PM	LENSAR Announces Presentations at American Academy of Ophthalmology Highlighting the Advantages of Streamline IV in Both Cataract and Astigmatism Corrective Surgery (Business Wire) -6.84%
Nov-09-20 04:01PM	LENSAR Reports Third Quarter 2020 Financial Results and Provides Business Update (Business Wire) +7.54% +8.60%
Nov-02-20 08:00AM	LENSAR to Hold Third Quarter 2020 Financial Results and Business Update Conference Call on Monday, November 9, 2020 (Business Wire)

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Winer Gary M	Director	Sep 03 '24	Buy	4.50	685	3,082	80,840	Sep 06 09:00 AM
Winer Gary M	Director	Aug 28 '24	Buy	4.45	1,000	4,450	80,155	Aug 29 06:05 AM
Winer Gary M	Director	Aug 26 '24	Buy	4.58	802	3,673	78,655	Aug 29 06:05 AM
Winer Gary M	Director	Aug 27 '24	Buy	4.50	500	2,250	79,155	Aug 29 06:05 AM
Winer Gary M	Director	Aug 21 '24	Buy	4.35	500	2,176	77,851	Aug 23 06:52 PM
Winer Gary M	Director	Aug 22 '24	Buy	4.30	2	9	77,853	Aug 23 06:52 PM
Winer Gary M	Director	Aug 20 '24	Buy	4.20	500	2,100	77,351	Aug 20 05:24 PM
Winer Gary M	Director	Aug 16 '24	Buy	4.03	6	24	76,851	Aug 20 05:24 PM
Winer Gary M	Director	Aug 14 '24	Buy	4.20	1,000	4,200	76,845	Aug 14 08:31 PM
Winer Gary M	Director	Aug 12 '24	Buy	4.03	500	2,015	75,845	Aug 14 08:31 PM
STAAB THOMAS R II	Chief Financial Officer	Aug 08 '24	Option Exercise	2.65	3,500	9,275	162,434	Aug 12 04:30 PM
Winer Gary M	Director	Nov 22 '23	Buy	2.10	300	630	53,345	Nov 27 07:30 PM
Winer Gary M	Director	Nov 16 '23	Buy	2.12	1,000	2,125	53,045	Nov 17 06:18 PM
Winer Gary M	Director	Nov 15 '23	Buy	2.15	500	1,075	52,045	Nov 17 06:18 PM
Winer Gary M	Director	Nov 10 '23	Buy	2.13	1,000	2,135	51,545	Nov 14 07:31 PM

GKOS

Glaukos Corporation

STAA

Staar Surgical Co.

LNSR

LENSAR Inc

Upgrade your FINVIZ experience